While tumors in the CD19 CAR-T control group grew progressively, mice infused with either B12(VHH)-CAR-T or C4(VHH)-CAR-T cells showed rapid tumor-shrinkage until mice were eventually tumor-free (Fig. 5e, f). Here, CD19 is linked to neoplasm.